Johns Hopkins Study Found Myeloma Care Disparities
Researchers identified significant gaps in bone-modifying drug administration between racial groups at the hospital.
Updated on Oct. 8, 2026 in Cancer
Live Poll
Do you trust that the healthcare system provides equal quality of care for all racial groups?
A review of medical records at Johns Hopkins Hospital revealed that African American myeloma patients received fewer doses of bone-modifying drugs than White patients. The findings highlight persistent inequities in the treatment of bone-related complications during the first year after diagnosis.
Why it matters
Addressing these disparities is critical to reducing skeletal-related events, which are a major source of morbidity for myeloma patients. Disparities in treatment adherence and delivery may exacerbate underlying health outcomes for minority populations.
A study of 350 patients revealed that African American patients received a median of five drug doses, compared to seven for White patients. Furthermore, 54% of African American patients had bone treatments delayed or skipped at diagnosis.
The players
Johns Hopkins Hospital
This is a world-renowned academic medical center located in Baltimore that serves as a hub for advanced cancer research and patient care.
The details
Researchers analyzed data from 149 African American and 201 White patients treated at Johns Hopkins Hospital. The study specifically tracked how often patients received essential bone-modifying medications during the first year of their cancer treatment.
Timeline
Records from January 2016 to December 2024 were reviewed for the study.
The findings were published in JCO Oncology Practice on October 1, 2026.
The Big Picture
This study follows a pattern set by the JCO Oncology Practice equity research initiatives by documenting systemic gaps in care. The findings illustrate a broader trend of identifying and quantifying racial healthcare disparities in oncology practices.
These findings suggest that patients and caregivers should proactively discuss bone-health treatment plans with their oncologists to ensure consistent care. Understanding these disparities can help families advocate for more equitable adherence to established medical protocols.
The takeaway
These results emphasize the necessity for clinical systems to audit and adjust treatment delivery to ensure all patients receive standard care. Targeted interventions may be required to bridge the gap in bone-health outcomes for vulnerable populations.
What happens next
Researchers plan to conduct further studies to determine if higher-intensity treatment regimens can effectively mitigate the increased risk of skeletal-related events in African American patients.
Further reading
Learn more about ongoing initiatives in Cancer care and research.
Source note: This article includes information reported by Curetoday.
Live Poll
Do you trust that the healthcare system provides equal quality of care for all racial groups?
